Relative Effects of Two Different Enoxaparin Regimens as Comparators Against Newer Oral Anticoagulants

The use of once-daily enoxaparin regimen as control in clinical trials will lead to more favorable estimates of relative efficacy for the new oral anticoagulants than if enoxaparin 30 mg bid had been chosen as a comparator.